American Research & Management Company’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $29K | Buy |
740
+40
| +6% | +$1.6K | 0.01% | 230 |
|
|
2022
Q2 | $26K | Hold |
700
| – | – | 0.01% | 237 |
|
|
2022
Q1 | $31K | Hold |
700
| – | – | 0.01% | 228 |
|
|
2021
Q4 | $30K | Hold |
700
| – | – | 0.01% | 232 |
|
|
2021
Q3 | $30K | Hold |
700
| – | – | 0.01% | 232 |
|
|
2021
Q2 | $30K | Sell |
700
-650
| -48% | -$27.3K | 0.01% | 240 |
|
|
2021
Q1 | $52K | Hold |
1,350
| – | – | 0.01% | 195 |
|
|
2020
Q4 | $49K | Hold |
1,350
| – | – | 0.01% | 203 |
|
|
2020
Q3 | $52K | Sell |
1,350
-450
| -25% | -$17.3K | 0.02% | 181 |
|
|
2020
Q2 | $63K | Hold |
1,800
| – | – | 0.02% | 173 |
|
|
2020
Q1 | $59K | Sell |
1,800
-200
| -10% | -$7.81K | 0.02% | 166 |
|
|
2019
Q4 | $90K | Hold |
2,000
| – | – | 0.03% | 160 |
|
|
2019
Q3 | $81K | Hold |
2,000
| – | – | 0.02% | 167 |
|
|
2019
Q2 | $86K | Hold |
2,000
| – | – | 0.03% | 173 |
|
|
2019
Q1 | $77K | Hold |
2,000
| – | – | 0.02% | 186 |
|
|
2018
Q4 | $71K | Hold |
2,000
| – | – | 0.02% | 163 |
|
|
2018
Q3 | $77K | Hold |
2,000
| – | – | 0.02% | 170 |
|
|
2018
Q2 | $65K | Hold |
2,000
| – | – | 0.02% | 160 |
|
|
2018
Q1 | $55K | Hold |
2,000
| – | – | 0.02% | 172 |
|
|
2017
Q4 | $50K | Hold |
2,000
| – | – | 0.02% | 192 |
|
|
2017
Q3 | $58K | Hold |
2,000
| – | – | 0.02% | 164 |
|
|
2017
Q2 | $55K | Hold |
2,000
| – | – | 0.02% | 164 |
|
|
2017
Q1 | $50K | Hold |
2,000
| – | – | 0.02% | 161 |
|
|
2016
Q4 | $43K | Hold |
2,000
| – | – | 0.01% | 185 |
|
|
2016
Q3 | $48K | Hold |
2,000
| – | – | 0.02% | 176 |
|
|
2016
Q2 | $47K | Hold |
2,000
| – | – | 0.02% | 168 |
|
|
2016
Q1 | $38K | Hold |
2,000
| – | – | 0.02% | 184 |
|
|
2015
Q4 | $37K | Hold |
2,000
| – | – | 0.02% | 184 |
|
|
2015
Q3 | $33K | Hold |
2,000
| – | – | 0.01% | 193 |
|
|
2015
Q2 | $35K | Hold |
2,000
| – | – | 0.01% | 199 |
|
|
2015
Q1 | $36K | Hold |
2,000
| – | – | 0.01% | 194 |
|
|
2014
Q4 | $27K | Hold |
2,000
| – | – | 0.01% | 209 |
|
|
2014
Q3 | $24K | Hold |
2,000
| – | – | 0.01% | 221 |
|
|
2014
Q2 | $26K | Hold |
2,000
| – | – | 0.01% | 222 |
|
|
2014
Q1 | $27K | Hold |
2,000
| – | – | 0.01% | 219 |
|
|
2013
Q4 | $24K | Hold |
2,000
| – | – | 0.01% | 229 |
|
|
2013
Q3 | $23K | Hold |
2,000
| – | – | 0.01% | 226 |
|
|
2013
Q2 | $19K | Buy |
+2,000
| New | +$17K | 0.01% | 233 |
|
Other funds holding BSX
BG
American Research & Management Company's BSX Position: Q3 2022 in Review
American Research & Management Company increased its Boston Scientific (BSX) stake by 5.7% in Q3 2022, buying an estimated $1.6K and bringing the position to 740 shares worth $29K. The position accounts for 0.01% of the portfolio, ranked #230.
American Research & Management Company first reported a position in BSX in Q2 2013 and has held it in 38 quarters since. The position peaked at $90K in Q4 2019. 865 funds tracked by Wall St. Rank hold BSX as of Q3 2022.
- American Research & Management Company held 740 shares of Boston Scientific worth $29K as of Q3 2022.
- American Research & Management Company bought 40 Boston Scientific shares in Q3 2022, an estimated $1.6K.
- Boston Scientific made up 0.01% of American Research & Management Company's portfolio in Q3 2022, its #230 holding.
- American Research & Management Company first reported a position in Boston Scientific in Q2 2013 and has held it in 38 quarters since.
- American Research & Management Company's Boston Scientific position peaked at $90K in Q4 2019.
- 865 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2022.
Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.